[ Price : $8.95]
Federal Register Notice: FDA seeks comments on recordkeeping requirements for institutional review boards.[ Price : $8.95]
Federal Register Notice: FDA extends the comment period on a 6/4 Federal Register notice on the proposed availability of de-identi...[ Price : $8.95]
During the current budget impasse on Capitol Hill and partial government shutdown, FDA says it cannot accept medical product submi...[ Price : $8.95]
FDA issues a guidance on developing and reviewing IDE applications for early feasibility studies of significant risk devices.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on a proposed collection of information contained in a guidance on citizen petitions a...[ Price : $8.95]
FDAs Florida District Office warns Nephron Pharmaceuticals that its Asthmanefrin is an unapproved new drug being marketed inapprop...[ Price : $8.95]
FDA warns Germans Epflex Feinwerktechnik about Quality System Regulation violations in its manufacturing of guidewire devices.[ Price : $8.95]
United Therapeutics tells FDA it supports Actelions petition asking that any generic Ventavis be approved with a nebulizer that ha...